Early measurable residual disease detection post-haematopoietic stem cell transplantation in acute myeloid leukaemia

Background: Detection of measurable residual disease (MRD) is becoming the standard of care in the prognostication of acute myeloid leukaemia post-chemotherapy, but its role in early post-haematopoietic stem cell transplantation (HSCT) is less defined. Objectives: This study aims to examine the role...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sze P. Tsui, Stephen S. Y. Lam, Chun H. Au, Chi Y. Fung, Beca B. K. Ip, Anthony T. C. Wong, Henry C. M. Leung, Wing H. Lai, Ho W. Ip, Edmond S. K. Ma, Garret M. K. Leung, Joycelyn P. Y. Sim, Anskar Y. H. Leung
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publishing 2025-11-01
Colección:Therapeutic Advances in Hematology
Acceso en línea:https://doi.org/10.1177/20406207251389815
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares